Materials Healthcare Sector

Neurocrine Biosciences

Market Cap: US$14.1b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Guardant Health

Market Cap: US$14.0b

A precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.

Summit Therapeutics

Market Cap: US$13.8b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

BridgeBio Pharma

Market Cap: US$13.7b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Tempus AI

Market Cap: US$13.5b

Operates as a healthcare technology company.

Madrigal Pharmaceuticals

Market Cap: US$13.4b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

ICON

Market Cap: US$13.3b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Ascendis Pharma

Market Cap: US$12.8b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Ionis Pharmaceuticals

Market Cap: US$12.7b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Fisher & Paykel Healthcare

Market Cap: NZ$21.6b

Designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally.

Viatris

Market Cap: US$12.2b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Cochlear

Market Cap: AU$18.3b

Provides implantable hearing solutions for children and adults worldwide.

Globus Medical

Market Cap: US$11.8b

A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Penumbra

Market Cap: US$11.7b

Designs, develops, manufactures, and markets medical devices in the United States and internationally.

Elanco Animal Health

Market Cap: US$11.5b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Revvity

Market Cap: US$11.4b

Provides health sciences solutions, technologies, and services.

Encompass Health

Market Cap: US$11.4b

Provides post-acute healthcare services in the United States and Puerto Rico.

Exelixis

Market Cap: US$11.4b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Jazz Pharmaceuticals

Market Cap: US$10.9b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Avidity Biosciences

Market Cap: US$10.7b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

BioMarin Pharmaceutical

Market Cap: US$10.7b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Ensign Group

Market Cap: US$10.6b

Provides skilled nursing, senior living, and rehabilitative services.

Align Technology

Market Cap: US$10.3b

Provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.

Qiagen

Market Cap: US$10.2b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Bio-Techne

Market Cap: US$9.9b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Repligen

Market Cap: US$9.7b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Moderna

Market Cap: US$9.4b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Doximity

Market Cap: US$9.4b

Operates as a digital platform for medical professionals in the United States.

Baxter International

Market Cap: US$9.3b

Through its subsidiaries, provides a portfolio of healthcare products in the United States.

HealthEquity

Market Cap: US$8.9b

Provides technology-enabled services platforms to consumers and employers in the United States.

Henry Schein

Market Cap: US$8.9b

Provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide.

Halozyme Therapeutics

Market Cap: US$8.7b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Bio-Rad Laboratories

Market Cap: US$8.6b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Hims & Hers Health

Market Cap: US$8.6b

Operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.

DaVita

Market Cap: US$8.4b

Provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

Charles River Laboratories International

Market Cap: US$8.4b

Charles River Laboratories International, Inc.